113 related articles for article (PubMed ID: 25005584)
1. RETRACTED ARTICLE: Preparation and characterization of novel lipid nanocapsules of ropivacaine for transdermal delivery.
Zhai Y; Zhao L; Wang Z; Zhai G
Drug Deliv; 2016; 23(2):619-28. PubMed ID: 25005584
[TBL] [Abstract][Full Text] [Related]
2. Ethosomes for skin delivery of ropivacaine: preparation, characterization and ex vivo penetration properties.
Zhai Y; Xu R; Wang Y; Liu J; Wang Z; Zhai G
J Liposome Res; 2015; 25(4):316-24. PubMed ID: 25625544
[TBL] [Abstract][Full Text] [Related]
3. Lipid nanocapsules for transdermal delivery of ropivacaine: in vitro and in vivo evaluation.
Zhai Y; Yang X; Zhao L; Wang Z; Zhai G
Int J Pharm; 2014 Aug; 471(1-2):103-11. PubMed ID: 24858383
[TBL] [Abstract][Full Text] [Related]
4. Preparation and characterization of tetrandrine-phospholipid complex loaded lipid nanocapsules as potential oral carriers.
Zhao YQ; Wang LP; Ma C; Zhao K; Liu Y; Feng NP
Int J Nanomedicine; 2013; 8():4169-81. PubMed ID: 24204145
[TBL] [Abstract][Full Text] [Related]
5. Polymeric versus lipid nanocapsules for miconazole nitrate enhanced topical delivery:
Abdel-Rashid RS; Helal DA; Alaa-Eldin AA; Abdel-Monem R
Drug Deliv; 2022 Dec; 29(1):294-304. PubMed ID: 35037528
[TBL] [Abstract][Full Text] [Related]
6. Boosting the In Vivo Transdermal Bioavailability of Asenapine Maleate Using Novel Lavender Oil-Based Lipid Nanocapsules for Management of Schizophrenia.
El-Tokhy FS; Abdel-Mottaleb MMA; Abdel Mageed SS; Mahmoud AMA; El-Ghany EA; Geneidi AS
Pharmaceutics; 2023 Feb; 15(2):. PubMed ID: 36839811
[TBL] [Abstract][Full Text] [Related]
7. Structural Characterization Study of a Lipid Nanocapsule Formulation Intended for Drug Delivery Applications Using Small-Angle Scattering Techniques.
Urimi D; Hellsing M; Mahmoudi N; Söderberg C; Widenbring R; Gedda L; Edwards K; Loftsson T; Schipper N
Mol Pharm; 2022 Apr; 19(4):1068-1077. PubMed ID: 35226500
[TBL] [Abstract][Full Text] [Related]
8. Formulation development and upscaling of lipid nanocapsules as a drug delivery system for a novel cyclic GMP analogue intended for retinal drug delivery.
Urimi D; Widenbring R; Pérez García RO; Gedda L; Edwards K; Loftsson T; Schipper N
Int J Pharm; 2021 Jun; 602():120640. PubMed ID: 33901599
[TBL] [Abstract][Full Text] [Related]
9. Development and characterization of lecithin stabilized glibenclamide nanocrystals for enhanced solubility and drug delivery.
Kumar BS; Saraswathi R; Kumar KV; Jha SK; Venkates DP; Dhanaraj SA
Drug Deliv; 2014 May; 21(3):173-84. PubMed ID: 24102185
[TBL] [Abstract][Full Text] [Related]
10. Preparation and Characterization of Puerarin-Loaded Lipid Nanocapsules.
Zhai Y; Liu M; Wan M; Li Y; Zhang M; Zhai G
J Nanosci Nanotechnol; 2015 Apr; 15(4):2643-9. PubMed ID: 26353476
[TBL] [Abstract][Full Text] [Related]
11. Development and characterization of a novel lipid nanocapsule formulation of Sn38 for oral administration.
Roger E; Lagarce F; Benoit JP
Eur J Pharm Biopharm; 2011 Sep; 79(1):181-8. PubMed ID: 21303693
[TBL] [Abstract][Full Text] [Related]
12. Lipid nanocapsules enhance the transdermal delivery of drugs regardless of their physico-chemical properties.
Kalvodová A; Zbytovská J
Int J Pharm; 2022 Nov; 628():122264. PubMed ID: 36209979
[TBL] [Abstract][Full Text] [Related]
13. Local anaesthetic pain relief therapy: In vitro and in vivo evaluation of a nanotechnological formulation co-loaded with ropivacaine and dexamethasone.
Zhang Y; Yue Y; Chang M
Biomed Pharmacother; 2017 Dec; 96():443-449. PubMed ID: 29031203
[TBL] [Abstract][Full Text] [Related]
14. Nose to brain delivery of melatonin lipidic nanocapsules as a promising post-ischemic neuroprotective therapeutic modality.
Bseiso EA; AbdEl-Aal SA; Nasr M; Sammour OA; El Gawad NAA
Drug Deliv; 2022 Dec; 29(1):2469-2480. PubMed ID: 35892291
[TBL] [Abstract][Full Text] [Related]
15. Ropivacaine loaded microemulsion and microemulsion-based gel for transdermal delivery: preparation, optimization, and evaluation.
Zhao L; Wang Y; Zhai Y; Wang Z; Liu J; Zhai G
Int J Pharm; 2014 Dec; 477(1-2):47-56. PubMed ID: 25304092
[TBL] [Abstract][Full Text] [Related]
16. Lipid nanocapsules as a new delivery system in copepods: Toxicity studies and optical imaging.
Stancheva S; Souissi A; Ibrahim A; Barras A; Spriet C; Souissi S; Boukherroub R
Colloids Surf B Biointerfaces; 2015 Nov; 135():441-447. PubMed ID: 26280818
[TBL] [Abstract][Full Text] [Related]
17. Long-circulating DNA lipid nanocapsules as new vector for passive tumor targeting.
Morille M; Montier T; Legras P; Carmoy N; Brodin P; Pitard B; Benoît JP; Passirani C
Biomaterials; 2010 Jan; 31(2):321-9. PubMed ID: 19800113
[TBL] [Abstract][Full Text] [Related]
18. Switching indication of PEGylated lipid nanocapsules-loaded with rolapitant and deferasirox against breast cancer: Enhanced in-vitro and in-vivo cytotoxicity.
Kabil MF; Mahmoud MY; Bakr AF; Zaafar D; El-Sherbiny IM
Life Sci; 2022 Sep; 305():120731. PubMed ID: 35753435
[TBL] [Abstract][Full Text] [Related]
19. Characterisation and Skin Distribution of Lecithin-Based Coenzyme Q10-Loaded Lipid Nanocapsules.
Zhou H; Yue Y; Liu G; Li Y; Zhang J; Yan Z; Duan M
Nanoscale Res Lett; 2010 Jul; 5(10):1561-9. PubMed ID: 21076708
[TBL] [Abstract][Full Text] [Related]
20. Enhanced Solubility and Permeability of Naringenin Across Non-Everted Sacs of Rat Small Intestine by Lipid Nanocapsules.
Vakilzadeh H; Varshosaz J; Soghrati S
Recent Pat Nanotechnol; 2021; 15(1):55-69. PubMed ID: 32735533
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
